Unveiling Progress: Advancements in Treatment and Genomics of Metastatic Breast Cancer |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
MDAnderson APP Onboarding Program - Oncology 102 |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$125.00 |
Oncology 101: (On-Demand) - Nebraska Medicine - Inpatient or Malignant Heme Ambulatory |
- 17.50 AMA PRA Category 1 Credit™
- 17.50 ANCC
- 3.25 Pharmacology
|
Enduring |
|
$125.00 |
Thrombotic Microangiopathies: Deeper Dive Into Effective Management Strategies |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Current Treatment Paradigms for Head and Neck Cancers |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Gynecologic Oncology: Pelvic Mass and Abnormal Bleeding |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Bispecific Therapy in Cancer Treatment |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
The Pyramid: Building Blocks for Successful Advanced Care Planning |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Oral Oncoloytic Therapy: How to Optimize Your Patients' Care |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) Winter 2024 |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$125.00 |
Neuroendocrine Neoplasms: Not All Hoofbeats Are Horses |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Oncology 101: (On-Demand) - Nebraska Medicine - Ambulatory - Omaha and Kearney |
- 17.50 AMA PRA Category 1 Credit™
- 17.50 ANCC
- 3.25 Pharmacology
|
Enduring |
|
$125.00 |
Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers (On-Demand) Fall 2023 |
- 17.50 AMA PRA Category 1 Credit™
- 17.50 ANCC
- 3.25 Pharmacology
|
Enduring |
|
$125.00 |
Revolutionizing Leukemia Treatment: Allogeneic Transplants, Engineered T Cell Therapy, and Navigating the Complexities of GVHD |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Clinical Features and Therapeutic Targets for Myeloproliferative Neoplasms |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |